Home
|
Learning Center
|
中文版
Publications
站内成果搜索:
搜索
A Photoactivatable Platinum(IV) Anticancer Complex Conjugated to the RNA Ligand Guanidinoneomycin
A Phase I/IIa Clinical Trial in Duchenne Muscular Dystrophy Using Systemically Delivered Morpholino Antisense Oligomer to Skip Exon 53 (SKIP-NMD)
A Phase II Dose-Escalation Study of Allogeneic Mesenchymal Precursor Cells in Patients With Ischemic or Nonischemic Heart Failure
A Phase II Study of 3 '-Deoxy-3 '-F-18-Fluorothymidine PET in the Assessment of Early Response of Breast Cancer to Neoadjuvant Chemotherapy: Results from ACRIN 6688
A Phase 2 Study of Concurrent Radiation Therapy, Temozolomide, and the Histone Deacetylase Inhibitor Valproic Acid for Patients With Glioblastoma
A Phase II Randomized Trial of Lycopene-Rich Tomato Extract Among Men with High-Grade Prostatic Intraepithelial Neoplasia
A Phase I Study of Everolimus and Docetaxel in Patients With Castration-Resistant Prostate Cancer
A Physics-Based Analytical Model for Perovskite Solar Cells
A Phase 2 study of L-asparaginase encapsulated in erythrocytes in elderly patients with Philadelphia chromosome negative acute lymphoblastic leukemia: The GRASPALL/GRAALL-SA2-2008 study
A Phase I Study of Continuous Oral Dosing of OSI-906, a Dual Inhibitor of Insulin-Like Growth Factor-1 and Insulin Receptors, in Patients with Advanced Solid Tumors
A Phaseolus vulgaris Diversity Panel for Andean Bean Improvement
A Physics-based Memristor Model Based on Chalcogenide Alloy
A Phase I Trial of DFMO Targeting Polyamine Addiction in Patients with Relapsed/Refractory Neuroblastoma
A Phase II, Single-Arm, Open-Label, Multicenter Study to Evaluate the Efficacy and Safety of P276-00, a Cyclin-Dependent Kinase Inhibitor, in Patients With Relapsed or Refractory Mantle Cell Lymphoma
A Phase 1 exercise dose escalation study for stroke survivors with impaired walking
A Phase I/II adaptive design to determine the optimal treatment regimen from a set of combination immunotherapies in high-risk melanoma
A Phosphetane Catalyzes Deoxygenative Condensation of alpha-Keto Esters and Carboxylic Acids via P-III/P-V=O Redox Cycling
A Phase 2 Trial of Oral Solithromycin 1200 mg or 1000 mg as Single-Dose Oral Therapy for Uncomplicated Gonorrhea
A Phase II Trial of Gefitinib in Combination with Bevacizumab as First-Line Therapy for Advanced Non-Small Cell Lung Cancer with Activating EGFR Gene Mutations: The Okayama Lung Cancer Study Group Trial 1001
A Phylogenetic Analysis of Lychnophorinae (Asteraceae: Vernonieae) Based on Molecular and Morphological Data
A Phenomenological Study of Obesity and Physical Activity in Southern African American Older Women
A Phase I Study of Midostaurin and Azacitidine in Relapsed and Elderly AML Patients
A Phase I Study of the Anti-Idiotype Vaccine Racotumomab in Neuroblastoma and Other Pediatric Refractory Malignancies
A Phenotype of Atypical Apraxia of Speech in a Family Carrying SQSTM1 Mutation
A Phase II Study of GW786034 (Pazopanib) With or Without Bicalutamide in Patients With Castration-Resistant Prostate Cancer
A Phase I/II adaptive design for heterogeneous groups with application to a stereotactic body radiation therapy trial
A Physiological, Rather Than a Superovulated, Post-Implantation Environment Can Attenuate the Compromising Effect of Assisted Reproductive Techniques on Gene Expression in Developing Mice Embryos
A Phase II Randomized Clinical Trial of a Nutritional Formulation for Cognition and Mood in Alzheimer's Disease
A Phase II, Open-Label Evaluation of Cysteamine Tolerability in Patients With Huntington's Disease
A Phase II Trial of Combined Chemotherapy with Oral S-1 and 24-Hour Infusions of Irinotecan plus Bevacizumab in Patients with Metastatic Colorectal Cancer
A Phonon Scattering Bottleneck for Carrier Cooling in Lead Chalcogenide Nanocrystals
A Phenylpropanoid, a Slovenolide, Two Sulphur-Containing Germacranes and Ca2+-ATPase Inhibitors from Thapsia villosa
A Phase II Study of an Herbal Decoction That Includes Astragali Radix for Cancer-Associated Anorexia in Patients With Advanced Cancer
A Photovoltaic Fiber Design for Smart Textiles
A Pharmacologically Active Monoclonal Antibody against the Human Melanocortin-4 Receptor: Effectiveness After Peripheral and Central Administration
A Phase I Pharmacologic Study of Necitumumab (IMC-11F8), a Fully Human IgG(1) Monoclonal Antibody Directed Against EGFR in Patients with Advanced Solid Malignancies
A Phase III Randomized Equivalence Study of Biosimilar Filgrastim versus Amgen Filgrastim in Patients Receiving Myelosuppressive Chemotherapy for Breast Cancer
A Phase II Study of Irinotecan With Biweekly, Low Dose Leucovorin and Bolus and Continuous Infusion 5-Fluorouracil (Modified FOLFIRI) as First Line Therapy For Patients With Recurrent or Metastatic Gastric Cancer
A Pharmaceutical Care Program to Improve Adherence to Statin Therapy: A Randomized Controlled Trial
A Phase 2 Study to Evaluate the Safety and Immunogenicity of a Recombinant HIV Type 1 Vaccine Based on Adeno-Associated Virus
A Phase I Study of Vandetanib in Combination with Vinorelbine/Cisplatin or Gemcitabine/Cisplatin as First-Line Treatment for Advanced Non-small Cell Lung Cancer
A Phase 2 Evaluation of Irofulven as Second-line Treatment of Recurrent or Persistent Intermediately Platinum-Sensitive Ovarian or Primary Peritoneal Cancer A Gynecologic Oncology Group Trial
A Phase 1/2, Dose-Escalation Trial of Deferasirox for the Treatment of Iron Overload in HFE-Related Hereditary Hemochromatosis
A Phase 2 Clinical Trial of nab-Paclitaxel in Previously Treated and Chemotherapy-Naive Patients With Metastatic Melanoma
A Photochemical Metallocene Route to Anionic Enediynes: Synthesis, Solid-State Structures, and ab Initio Computations on Cyclopentadienidoenediynes
A Phase II Study of PD-0325901, an Oral MEK Inhibitor, in Previously Treated Patients with Advanced Non-Small Cell Lung Cancer
A Phase III Study of Belatacept-based Immunosuppression Regimens versus Cyclosporine in Renal Transplant Recipients (BENEFIT Study)
A Phase III Study of Belatacept Versus Cyclosporine in Kidney Transplants from Extended Criteria Donors (BENEFIT-EXT Study)
A Phase II Study of Sorafenib in Malignant Mesothelioma Results of Cancer and Leukemia Group B 30307
A Photochemical Precursor for Carbon Monoxide Release in Aerated Aqueous Media
A Phase IIa Open-Label Dose-Escalation Pilot Study Using Allogeneic Human Dermal Fibroblasts for Nasolabial Folds
A Phylogeny and Timescale for the Evolution of Pseudocheiridae (Marsupialia: Diprotodontia) in Australia and New Guinea
A Physiologic-Based Approach to the Evaluation of a Patient With Hypokalemia
A Physiologic-Based Approach to the Evaluation of a Patient With Hyperkalemia
A Phosphatidylinositol 3-Kinase/Protein Kinase B-independent Activation of Mammalian Target of Rapamycin Signaling Is Sufficient to Induce Skeletal Muscle Hypertrophy
A Phase II Study of Oxaliplatin, 5-Fluorouracil, Leucovorin, and High-Dose Capecitabine in Patients With Metastatic Colorectal Cancer
A Phase Function to Quantify Serial Dependence between Discrete Samples
A Phase II Study of Dasatinib in Patients with Chemosensitive Relapsed Small Cell Lung Cancer (Cancer and Leukemia Group B 30602)
A Phosphate-buffered Saline Intracanal Dressing Improves the Biomineralization Ability of Mineral Trioxide Aggregate Apical Plugs
A Photovoltaic Device Using an Electrolyte Containing Photosynthetic Reaction Centers
A Phase I Trial of Deep Brain Stimulation of Memory Circuits in Alzheimer's Disease
A Physiologically-Based Model for Simulation of Color Vision Deficiency (vol 15, pg 1291, 2009)
A Pharmacokinetic and Pharmacodynamic Study of Oral Oxycodone in a Human Experimental Pain Model of Hyperalgesia
A Pharmacokinetic Study of Plerixafor in Subjects with Varying Degrees of Renal Impairment
A Phase 2 Study of Platinum and Gemcitabine in Patients With Advanced Salivary Gland Cancer A Trial of the NCIC Clinical Trials Group
A Phase II Trial of Sorafenib in Metastatic Melanoma with Tissue Correlates
A Phase II Trial of the Epothilone B Analog Ixabepilone (BMS-247550) in Patients with Metastatic Melanoma
A Phenethyl bromo ester from Citharexylum fruticosum
A Phase III Randomized Trial of Lobectomy Versus Limited Resection for Small-sized Peripheral Non-small Cell Lung Cancer (JCOG0802/WJOG4607L)
A Phase II Study of Sunitinib in Japanese Patients with Metastatic Renal Cell Carcinoma: Insights into the Treatment, Efficacy and Safety
A Phase IA, Open-label, Dose-escalating Study of PTK787/ZK 222584 Administered Orally on a Continuous Dosing Schedule in Patients with Advanced Cancer
A Photochemical Study of Diclofenac and Its Major Transformation Products
A Phase III Trial of Paclitaxel plus Carboplatin Versus Paclitaxel plus Cisplatin in Stage IVB, Persistent or Recurrent Cervical Cancer: Gynecologic Cancer Study Group/Japan Clinical Oncology Group Study (JCOG0505)
A Phosphodiesterase III Inhibitor Protects Rat Liver From Sinusoidal Obstruction Syndrome Through Heme Oxygenase-1 Induction Reply
A Phenolic Antioxidant Releasing Nitric Oxide on Demand
A Phylogenomic Approach to Resolve the Arthropod Tree of Life
A Physicist's Perspective on "Views on Macroscopic Kinetics of Plasma Polymerisation"
A Phase 2 Multicenter Study of Irinotecan and Cisplatinum as Neoadjuvant Treatment in Patients With Locally Advanced Cervical Cancer
A Photoinitiator-Free Photosensitive Polyimide with Low Dielectric Constant
A Phase II Study of a Combined Biweekly Irinotecan and Monthly Cisplatin Treatment for Metastatic or Recurrent Gastric Cancer
A Pharmacovigilance Program From Laboratory Signals for the Detection and Reporting of Serious Adverse Drug Reactions in Hospitalized Patients
A Phase II Trial of Less Than 7 Weeks of Concomitant Cisplatin-Paclitaxel Chemoradiation in Locally Advanced Cervical Cancer
A Phase II Study of Irinotecan, Continuous 5-Fluorouracil, and Leucovorin (FOLFIRI) Combination Chemotherapy for Patients With Recurrent or Metastatic Gastric Cancer Previously Treated With a Fluoropyrimidine-Based Regimen